Skip to content
Lysoway Therapeutics
About Us
Overview
Our Team
Board of Directors
Investors
Science
Our Approach
Pipeline
TRPML1
TMEM175
News
Contact
Leadership Team
Adam Sun, MBA
Board Observer, Oceanpine Capital
Back to Board of Directors